A listing of recent Commerce Department antidumping and countervailing duty messages posted on CBP's website March 17, along with the case number(s) and CBP message number, is provided below. The messages are available by searching for the listed CBP message number at CBP's ADCVD Search page.
When the Office of the U.S. Trade Representative asked for comments on policies that reduce U.S. exports, most agricultural trade associations -- and a few companies -- laid out their concerns about tariffs or sanitary and phytosanitary (SPS) barriers that prevent their exports from reaching their potential.
Treasury Secretary Scott Bessent offered some clarity on the promised April 2 tariffs but, when pressed, didn't elaborate on vital details. He said that reciprocal tariffs would take the form of a number that the Trump administration "believe[s] represents their tariffs," but said he wasn't sure if tariffs would layer on top of Section 232 tariffs.
Trade and patent attorney James Jeffries has rejoined Kutak Rock as an attorney in the intellectual property and corporate practice group, the firm announced. Jeffries worked as chief legal officer at Kuat Innovations from 2021 to 2025 after initially working for Kutak Rock as an attorney and partner from 2018 to 2021. At Kutak, Jeffries will work on trademark and patent matters, along with customs and international trade issues, including tariff exposure mitigation and vendor relationship structuring.
The entire international trade practice of Curtis Mallet-Prevost has joined Pillsbury Winthrop, Pillsbury announced on March 17. Led by partners Daniel Porter, Matthew McCullough and James Durling, the 14-member trade team will greatly expand Pillsbury's international trade practice, the firm said. Porter was the head of Curtis' trade practice, initially joining the firm in 2012.
The International Trade Commission published notices in the March 14 Federal Register on the following antidumping and countervailing duty (AD/CVD) injury, Section 337 patent or other trade proceedings (any notices that warrant a more detailed summary will be in another ITT article):
The International Trade Commission has ended a Section 337 investigation on imports of hydrodermabrasion systems (ITC Inv. No. 337-TA-1416), it said in a notice to be published March 18. Complainant HydraFacial initially alleged in 2024 that Sinclair Pharma’s U.S. and U.K. branches, as well as Huadong Medicine, EMA Aesthetics, Aesthetics Management Partners, Advanced Aesthetics Services and H.R. Meditech, are infringing patents related to HydraFacial’s systems for skin treatment through mechanical or fluid-based abrasion or exfoliation (see 2409100036).
The Commerce Department published notices in the Federal Register March 17 on the following antidumping and countervailing duty (AD/CVD) proceedings (any notices that announce changes to AD/CVD rates, scope, affected firms or effective dates will be detailed in another ITT article):
On March 14, the FDA posted new and revised versions of the following Import Alerts on the detention without physical examination of:
The Foreign-Trade Zones Board issued the following notices on March 17: